Gerosynth Labs Announces Investigational New Animal Drug (INAD) Acceptances Spanning Equine, Feline, and Canine Oncology

Gerosynth Labs, Inc., a private biotechnology company pioneering novel oncology and cellular-health therapeutics, today ...